Hims & Hers Health Inc Ordinary Shares - Class A (HIMS)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

$37.10

Buy

$37.39

arrow-down$-0.56 (-1.48%)

Prices updated at 13 Dec 2025, 00:59 EST

Prices minimum 15 mins delay

Prices in USD

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Chairman

Mr. Andrew Dudum

CEO

Mr. Andrew Dudum

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

1,637

Head office

2269 Chestnut Street

San Francisco

United States

94123

+1 415 851-0195

-

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Mike Chi Chief Operating Officer	0.49m
Mr. Kare Schultz Independent Director	0.02m
Mr. David Bolling Wells Lead Independent Director	0.08m
Mr. Christopher D. Payne Independent Director	0.04m
Ms. Anja L. Manuel Independent Director	0.04m
Mr. Andrew Dudum Chief Executive Officer and Chairman of the Board	0.57m
Dr. Patrick Carroll, M.D. Director and Chief Medical Officer	0.04m
Ms. Soleil Boughton Chief Legal Officer and Corporate Secretary	0.46m
Dr. Delos Cosgrove, M.D. Independent Director	0.04m
Ms. Andrea G. Perez Garcia Independent Director	0.06m
Ms. Irene Becklund Principal Accounting Officer, Senior Vice President and Controller	-
Ms. Deborah M. Autor Independent Director	0.01m
Mr. Oluyemi Okupe Chief Financial Officer	0.50m
Ms. Christiane Pendarvis Independent Director	0.05m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
JPMorgan Chase & Co	35,572,170
BlackRock Inc	25,145,814
Vanguard Group Inc. ( Junked)	18,236,394
Capital World Investors	18,783,194
Capital Research and Management Company	18,756,579

Director dealings

Date chevron-l-regular chevron-r-regular	Action
27 Dec 2024	-
27 Dec 2024	-
27 Dec 2024	-
27 Dec 2024	-
26 Dec 2024	-
24 Dec 2024	-
24 Dec 2024	-
24 Dec 2024	-
20 Dec 2024	-
20 Dec 2024	-
20 Dec 2024	-
20 Dec 2024	-
19 Dec 2024	-
19 Dec 2024	-
19 Dec 2024	-
13 Dec 2024	-
13 Dec 2024	-
13 Dec 2024	-
13 Dec 2024	-
17 Dec 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.